Compare AVNW & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVNW | TECX |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | 51 |
| Industry | Radio And Television Broadcasting And Communications Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.0M | 393.0M |
| IPO Year | 2007 | N/A |
| Metric | AVNW | TECX |
|---|---|---|
| Price | $24.62 | $33.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $34.67 | ★ $80.40 |
| AVG Volume (30 Days) | 92.8K | ★ 380.4K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $243,858,000.00 | N/A |
| Revenue This Year | $5.59 | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | $55.73 | ★ N/A |
| Revenue Growth | ★ 0.56 | N/A |
| 52 Week Low | $15.84 | $13.70 |
| 52 Week High | $27.02 | $35.99 |
| Indicator | AVNW | TECX |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 67.84 |
| Support Level | $24.20 | $16.83 |
| Resistance Level | $24.74 | $35.99 |
| Average True Range (ATR) | 1.00 | 2.81 |
| MACD | -0.16 | 0.91 |
| Stochastic Oscillator | 15.43 | 80.72 |
Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.